Brief: Xspray Pharma Q3 Pretax Loss Widens To SEK 11.6 Million
20/11/2020 06:48
Nov 20 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* Q3 PRETAX LOSS SEK 11.6 MILLION VERSUS LOSS SEK 9.9
MILLION YEAR
AGO
Source text: https://bit.ly/2IUkI4F
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003